Overview

Adaptive Radiation in Anal Cancer

Status:
Recruiting
Trial end date:
2028-12-31
Target enrollment:
Participant gender:
Summary
This is a 20 patient pilot study to examine the feasibility of dose-adapted radiation therapy for the treatment of locally advanced anal squamous cell cancer. The tumor and a patient's anatomy may change during radiation treatment and daily adaption of the radiation plan (i.e., a new daily plan based on the anatomy of the day) may help to maximize the dose to the tumor and minimize the radiation dose to the normal surrounding organs.
Phase:
N/A
Details
Lead Sponsor:
Columbia University
Collaborator:
Varian
Treatments:
Capecitabine
Fluorouracil
Mitomycin
Mitomycins